Skip to main content

Your basket

Your basket is empty. Continue shopping to add products to your basket.

Your quote list

Your quote list is empty. Continue browsing to add products to your quote list.

Search our catalogue

Call Centre

Request Quote

View Content

Please complete the form below to receive the requested content from Astrea Bioseparations. We will use the data you provide to send you relevant updates, special offers, and product-related information. See our Privacy Notice for details on how we use personal data.

If you have an account please log in to gain access to content. You can apply for an account here

Please enter a First Name

Please enter a valid First Name, the maximum length is 50 characters.

Please enter a Last Name

Please enter a valid Last Name, the maximum length is 50 characters.

Please enter a Company Name

Please enter a valid Company, the maximum length is 100 characters

Please enter a valid Email AddressPlease enter a valid Email AddressThe Email Address entered is already registered, please sign in with the Email Address or enter a different one

Please select a valid Telephone Number, the maximum length is 30 characters

Please enter a valid Telephone Number consisting only of the following characters and spaces ( ) + 0 1 2 3 4 5 6 7 8 9

Please select a State / Province / Territory

Please select a valid State / Province / Territory, the maximum length is 150 characters

Please select a Country

Data entered into form will be stored in your session (not in a cookie) to avoid having to re-enter in future form submissions.

Adeno-Associated Virus (AAV)

Adeno-associated virus (AAV) purification is a critical step in the production and application of AAV vectors, which have become essential tools in gene therapy and genetic research. AAVs are known for their safety, efficiency, and long-lasting gene expression, but the presence of impurities in AAV preparations can hinder their therapeutic and research potential. Purification processes, often involving chromatography and ultracentrifugation, help concentrate and isolate AAV particles while removing contaminants such as cellular debris, other viral particles, and host cell proteins. This purification ensures that AAV vector preparations are of high purity and potency, minimizing the risk of adverse immune responses and enhancing the precision of gene delivery. AAV purification is vital for developing safe and effective gene therapies and for conducting precise genetic studies, making it a cornerstone of the rapidly evolving field of gene-based medicine and genetic research.

Our Solutions

After primary capture, remove host cell contaminants using HCPure™.

Mixed mode polishing can increase sample purity while minimizing the risks of capsid loss.

  • Orthogonal mixed mode binding interactions remove host cell contaminants
  • Over 99% recovery of AAV2 capsids
  • Over 80% of host cell contamination removed

Shop the Range

Strong cation exchange resins for AAV capsid capture using SP PuraBead® P6HF.

  • Suitable for capture of wild, recombinant and mutant AAV serotypes
  • Caustic stable for high performance over multiple CIP cycles
  • Greater than 70% recovery of multiple CIP cycles
  • No ad5 co-elution

Shop the Range

Use strong anion exchange resins to enrich your AAV samples after capture and polishing.

Q PuraBead® P6HF separates empty and full capsids, ensuring therapeutic potency and effectiveness.

  • Greater than 70% recovery of full AAV 8 capsids
  • Caustic stable for high performance over multiple CIP cycles
  • Flexible and scalable from benchtop to production scale

Shop the Range

Resources

Brochures

User Guides

    Posters & Graphics

    Videos

    Blogs

    Call Centre Product Compare